Literature DB >> 18025173

Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes.

Rajan M Thomas1, Neelanjana Chunder, Chunxia Chen, Sarah E Umetsu, Susan Winandy, Andrew D Wells.   

Abstract

T cell activation results in dynamic remodeling of the chromatin at the IL2 promoter and induction of IL2 gene transcription. These processes are each dependent upon CD28 costimulation, but the molecular basis for this requirement is not clear. The IL2 promoter contains consensus-binding elements for Ikaros, a lymphocyte-specific zinc-finger DNA-binding protein that can regulate gene expression by recruiting chromatin-remodeling complexes. We find that native Ikaros in CD4(+) T cells exhibits sequence-specific binding to these elements in vitro, and interacts with the endogenous IL2 promoter in vivo, in a manner dependent upon its DNA-binding domain. This binding has important consequences on the regulation of the IL2 gene, because CD4(+) T cells with reduced Ikaros DNA-binding activity no longer require signals from the TCR or CD28 for histone acetylation at the endogenous IL2 promoter, and no longer require CD28 costimulation for expression of the IL2 gene. Furthermore, CD4(+) T cells with reduced Ikaros activity are resistant to clonal anergy induced by TCR ligation in the absence of either CD28 or IL-2R signals. These results establish Ikaros as a transcriptional repressor of the IL2 gene that functions through modulation of chromatin structure and has an obligate role in the induction of anergy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025173     DOI: 10.4049/jimmunol.179.11.7305

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Conserved intergenic elements and DNA methylation cooperate to regulate transcription at the il17 locus.

Authors:  Rajan M Thomas; Hong Sai; Andrew D Wells
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Two-step binding of transcription factors causes sequential chromatin structural changes at the activated IL-2 promoter.

Authors:  Satoru Ishihara; Ronald H Schwartz
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

3.  Ikaros sets the potential for Th17 lineage gene expression through effects on chromatin state in early T cell development.

Authors:  Larry Y Wong; Julianne K Hatfield; Melissa A Brown
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

4.  Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism.

Authors:  José C Crispín; Sokratis A Apostolidis; Florencia Rosetti; Marton Keszei; Ninghai Wang; Cox Terhorst; Tanya N Mayadas; George C Tsokos
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

Review 5.  Molecular mechanisms of T-cell tolerance.

Authors:  Roza I Nurieva; Xindong Liu; Chen Dong
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

6.  Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.

Authors:  Christian H Gabriel; Fridolin Gross; Martin Karl; Heike Stephanowitz; Anna Floriane Hennig; Melanie Weber; Stefanie Gryzik; Ivo Bachmann; Katharina Hecklau; Jürgen Wienands; Johannes Schuchhardt; Hanspeter Herzel; Andreas Radbruch; Eberhard Krause; Ria Baumgrass
Journal:  J Biol Chem       Date:  2016-09-16       Impact factor: 5.157

7.  Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.

Authors:  Shaun O'Brien; Rajan M Thomas; Gerald B Wertheim; Fuqin Zhang; Hao Shen; Andrew D Wells
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

Review 8.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

9.  IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes.

Authors:  Myrianne Duré; Fernando Macian
Journal:  Mol Immunol       Date:  2008-11-05       Impact factor: 4.407

10.  The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma.

Authors:  Mohamed H S Awwad; Katharina Kriegsmann; Julian Plaumann; Michael Benn; Jens Hillengass; Marc S Raab; Uta Bertsch; Markus Munder; Katja Weisel; Hans Jürgen Salwender; Mathias Hänel; Roland Fenk; Jan Dürig; Carsten Müller-Tidow; Hartmut Goldschmidt; Michael Hundemer
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.